Attenuated Disease in SIV-Infected Macaques Treated with
a Monoclonal Antibody against FasL

Attenuated Disease in SIV-Infected Macaques Treated with a Monoclonal Antibody against FasL

Acute SIVmac infection in macaques is accompanied by high levels of plasma viremia that decline with the appearance of viral immunity and is a model for acute HIV disease in man. Despite specific immune responses, the virus establishes a chronic, persistent infection. The destruction of CD4+ and C...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria S. Salvato, C. Cameron Yin, Hideo Yagita, Toshihiro Maeda, Ko Okumura, Ilia Tikhonov, C. David Pauza
Format:	Article
Language:	English
Published:	Wiley 2007-01-01
Series:	Clinical and Developmental Immunology
Online Access:	http://dx.doi.org/10.1155/2007/93462
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Fas/FasL System in Reproduction: Survival and Apoptosis
by: Gil Mor, et al.
Published: (2002-01-01)

Associations of serum soluble Fas and Fas ligand (FasL) with outcomes in systemic lupus erythematosus
by: Fabien B Vincent, et al.
Published: (2020-10-01)

Fas/FasL 在复发性自然流产患者中的表达
by: 刘玉昆
Published: (2004-01-01)

Serum Fas/FasL levels in dependence on clinical presentations of coronary disease and their relationship with risk factors
by: Ristić Tatjana, et al.
Published: (2010-01-01)

EVIDENCE-BASED RELATIONSHIP BETWEEN THE LEVELS OF IL-6, VECF, sFas, FasL AND ENDOSTATIN IN PATIENTS WITH OVARIAN NEOPLASMS
by: N. Ye. Kushlinsky, et al.
Published: (2014-09-01)

Association of the polymorphisms in the Fas/FasL promoter regions with cancer susceptibility: a systematic review and meta-analysis of 52 studies.
by: Yeqiong Xu, et al.
Published: (2014-01-01)

Platelet aggregation elicits FasL expression and hepatocyte apoptosis in sinusoidal obstruction syndrome
by: Yuri Higashi, et al.
Published: (2025-05-01)

Involvement of FOXO transcription factors, TRAIL-FasL/Fas, and sirtuin proteins family in canine coronavirus type II-induced apoptosis.
by: Gabriella Marfè, et al.
Published: (2011-01-01)

Statement of Retraction: A novel Fas-binding outer membrane protein and lipopolysaccharide of Leptospira interrogans induce macrophage apoptosis through the Fas/FasL-caspase-8/-3 pathway
Published: (2023-12-01)

Acetylated Dendrobium huoshanense polysaccharide: a novel inducer of apoptosis in colon cancer cells via Fas–FasL pathway activation and metabolic reprogramming
by: Liang Yao, et al.
Published: (2025-03-01)

A Mathematical Model of Receptor-Mediated Apoptosis: Dying to Know Why FasL is a Trimer
by: Ronald Lai, et al.
Published: (2004-06-01)

Combining a rhesus cytomegalovirus/SIV vaccine with a neutralizing antibody to protect against SIV challenges in rhesus macaques
by: Jessica Coppola, et al.
Published: (2025-06-01)

Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.
by: Eugene V Barsov, et al.
Published: (2011-01-01)

Early potent protection against heterologous SIVsmE660 challenge following live attenuated SIV vaccination in Mauritian cynomolgus macaques.
by: Neil Berry, et al.
Published: (2011-01-01)

SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.
by: Omotayo Farinre, et al.
Published: (2025-01-01)

Cytotoxic capacity of SIV-specific CD8(+) T cells against primary autologous targets correlates with immune control in SIV-infected rhesus macaques.
by: Daniel Mendoza, et al.
Published: (2013-02-01)

NFATc1 is a tumor suppressor in hepatocellular carcinoma and induces tumor cell apoptosis by activating the FasL‐mediated extrinsic signaling pathway
by: Sanrong Xu, et al.
Published: (2018-09-01)

Cytofluorymetryczna analiza wybranych markerów apoptozy Fas/FasL (CD95/CD95L) w tkance gruczołu tarczowego u młodocianych pacjentów z chorobą Gravesa-Basedowa oraz zapaleniem tarczycy typu Hashimoto
by: Artur Bossowski, et al.
Published: (2006-06-01)

Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques
by: Jennifer Tisoncik-Go, et al.
Published: (2025-03-01)

Pre-challenge gut microbial signature predicts RhCMV/SIV vaccine efficacy in rhesus macaques
by: Hayden N. Brochu, et al.
Published: (2024-11-01)

Booster vaccination is required to elicit and maintain COVID-19 vaccine-induced immunity in SIV-infected macaques
by: Pingchao Li, et al.
Published: (2023-12-01)

Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaques.
by: Sarah J Byrnes, et al.
Published: (2023-03-01)

Purging viral latency by a bifunctional HSV-vectored therapeutic vaccine in chronically SIV-infected macaques
by: Ziyu Wen, et al.
Published: (2025-04-01)

CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cells.
by: Luca Micci, et al.
Published: (2014-10-01)

ADCC develops over time during persistent infection with live-attenuated SIV and is associated with complete protection against SIV(mac)251 challenge.
by: Michael D Alpert, et al.
Published: (2012-01-01)

Inhibition of adaptive immune responses leads to a fatal clinical outcome in SIV-infected pigtailed macaques but not vervet African green monkeys.
by: Jörn E Schmitz, et al.
Published: (2009-12-01)

Tracking KLRC2 (NKG2C)+ memory-like NK cells in SIV+ and rhCMV+ rhesus macaques.
by: Daniel R Ram, et al.
Published: (2018-05-01)

SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution
by: Megan N. Fredericks, et al.
Published: (2025-05-01)

Distinct phenotype, longitudinal changes of numbers and cell-associated virus in blood dendritic cells in SIV-infected CD8-lymphocyte depleted macaques.
by: Caroline Soulas, et al.
Published: (2015-01-01)

Transient viral replication during analytical treatment interruptions in SIV infected macaques can alter the rebound-competent viral reservoir.
by: Taina T Immonen, et al.
Published: (2021-06-01)

Complement-mediated virus infectivity neutralisation by HLA antibodies is associated with sterilising immunity to SIV challenge in the macaque model for HIV/AIDS.
by: Mark Page, et al.
Published: (2014-01-01)

Maintenance of intestinal Th17 cells and reduced microbial translocation in SIV-infected rhesus macaques treated with interleukin (IL)-21.
by: Suresh Pallikkuth, et al.
Published: (2013-01-01)

CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation.
by: John T Loffredo, et al.
Published: (2007-11-01)

Long-term programming of antigen-specific immunity from gene expression signatures in the PBMC of rhesus macaques immunized with an SIV DNA vaccine.
by: Sarah E Belisle, et al.
Published: (2011-01-01)

Early antiretroviral therapy in SIV-infected rhesus macaques reveals a multiphasic, saturable dynamic accumulation of the rebound competent viral reservoir.
by: Brandon F Keele, et al.
Published: (2024-04-01)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
by: Juan José Bollain-y-Goytia, et al.
Published: (2014-01-01)

Mitigation of endemic GI-tract pathogen-mediated inflammation through development of multimodal treatment regimen and its impact on SIV acquisition in rhesus macaques.
by: Rachele M Bochart, et al.
Published: (2021-05-01)

Effects of treatment with suppressive combination antiretroviral drug therapy and the histone deacetylase inhibitor suberoylanilide hydroxamic acid; (SAHA) on SIV-infected Chinese rhesus macaques.
by: Binhua Ling, et al.
Published: (2014-01-01)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques.
by: Moritz Ries, et al.
Published: (2017-07-01)

The Secretion of IL-22 from Mucosal NKp44+ NK Cells Is Associated with Microbial Translocation and Virus Infection in SIV/SHIV-Infected Chinese Macaques
by: Wei Wang, et al.
Published: (2014-01-01)